For individuals battling Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a debilitating condition, the arrival of this treatment and Tafamidis meglumine represents a genuine change. These novel therapies protect the transthyretin protein, preventing its damaging build-up and reducing the severity of the condition . People are now seeing improvem… Read More